We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A scientist pipetting into an assay plate.

AI Method Accelerates Drug Discovery for Parkinson’s 10-Fold, Study Finds

A purple human brain.

Antipsychotic Use in Dementia Linked to Elevated Health Risks

Umbrella-shaped antibacterial toxin particles drifting toward and engaging a bacterial target cell.

Soil Bacteria Produce Unique Antimicrobial Particles

Study Investigates Links Between HIV Drugs and Reduced Alzheimer’s Disease Incidence

Scientists Pinpoint Brain Region Crucial for Attention Control

Targeted Liver Cancer Treatment May Help Cut Side Effects

News

Ablynx, Eddingpharm Sign Exclusive License Agreement

Under the terms of the agreement, Eddingpharm will be responsible for the clinical development, registration and commercialisation in Greater China of anti-TNFa Nanobody therapeutics.

New Advances in the Pre-clinical Evaluation of Hepatitis B Therapies

Imperial College London to present first public HBV Data from CN Bio in vitro liver model.

Dezima Reports Positive Results in its Phase 2b TULIP Trial

Combines outstanding efficacy and safety profile with favourable pharmacokinetics.

New NIH Research Awards to Address Multiple Chronic Conditions

Grants funded through the National Institutes of Health's HCS Research Collaboratory.

Recipharm to Acquire Corvette for SEK 1.1 Billion

Corvette will contribute to Company’s Intellectual Property backed manufacturing business.

AB SCIEX and Dalton Collaborate to Advance ADC Analysis

Collaboration supports movement to develop targeted anti-body based therapies.

Novo Nordisk Buys New Hampshire Production Plant

Novo Nordisk announced the acquisition of a manufacturing facility in West Lebanon, New Hampshire, USA, from Olympus Biotech.

NIH to Launch Human Safety Study of Ebola Vaccine Candidate

Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines.

Robert Hureau Joins PPD

Company appoints Robert Hureau as executive vice president and chief financial officer.

Donald Johns Joins Biogen Idec to Lead ALS Innovation Hub

Renowned neurologist to focus on accelerating the Company’s discovery and development of ALS therapies.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter